GCTK vs. SSKN, NXGL, MBOT, TTOO, MHUA, PETV, BTCY, PAVM, PSTV, and NURO
Should you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include STRATA Skin Sciences (SSKN), NEXGEL (NXGL), Microbot Medical (MBOT), T2 Biosystems (TTOO), Meihua International Medical Technologies (MHUA), PetVivo (PETV), Biotricity (BTCY), PAVmed (PAVM), Plus Therapeutics (PSTV), and NeuroMetrix (NURO). These companies are all part of the "surgical & medical instruments" industry.
GlucoTrack (NASDAQ:GCTK) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk.
10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are held by institutional investors. 17.7% of GlucoTrack shares are held by insiders. Comparatively, 40.4% of STRATA Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
GlucoTrack has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -32.47%. STRATA Skin Sciences' return on equity of -52.50% beat GlucoTrack's return on equity.
STRATA Skin Sciences has a consensus price target of $3.80, suggesting a potential upside of 894.24%. Given STRATA Skin Sciences' higher possible upside, analysts clearly believe STRATA Skin Sciences is more favorable than GlucoTrack.
GlucoTrack has a beta of 0.1, meaning that its stock price is 90% less volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500.
STRATA Skin Sciences received 223 more outperform votes than GlucoTrack when rated by MarketBeat users.
GlucoTrack has higher earnings, but lower revenue than STRATA Skin Sciences. GlucoTrack is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, STRATA Skin Sciences had 4 more articles in the media than GlucoTrack. MarketBeat recorded 6 mentions for STRATA Skin Sciences and 2 mentions for GlucoTrack. GlucoTrack's average media sentiment score of 1.43 beat STRATA Skin Sciences' score of 0.87 indicating that GlucoTrack is being referred to more favorably in the media.
Summary
STRATA Skin Sciences beats GlucoTrack on 11 of the 14 factors compared between the two stocks.
Get GlucoTrack News Delivered to You Automatically
Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GCTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GlucoTrack Competitors List
Related Companies and Tools
